Biological cell processing chip

- NanoCav, LLC
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is an isometric view of a biological cell processing chip in accordance with our new design;

FIG. 2 is a front elevation view thereof;

FIG. 3 is a rear elevation view thereof;

FIG. 4 is a right side elevation view thereof;

FIG. 5 is a left side elevation view thereof;

FIG. 6 is a top plan view thereof;

FIG. 7 is a bottom plan view thereof;

FIG. 8 is an isometric view of the biological cell processing chip of FIGS. 1-7 in a state of use;

FIG. 9 is an isometric view of another embodiment of a biological cell processing chip in accordance with our new design;

FIG. 10 is a front elevation view thereof;

FIG. 11 is a rear elevation view thereof;

FIG. 12 is a right side elevation view thereof;

FIG. 13 is a left side elevation view thereof;

FIG. 14 is a top plan view thereof;

FIG. 15 is a bottom plan view thereof; and,

FIG. 16 is an isometric view of the biological cell processing chip of FIGS. 9-15 in a state of use.

The broken lines in FIGS. 1-7 and 9-15, the areas within them, and the unshaded areas bounded by broken lines and solid lines depict portions of the biological cell processing chip that form no part of the claimed design. The additional broken lines shown in FIGS. 8 and 16 depict environmental subject matter and form no part of the claimed design.

Claims

The ornamental design for a biological cell processing chip, as shown and described.

Referenced Cited
U.S. Patent Documents
5955028 September 21, 1999 Chow
6074605 June 13, 2000 Meserol et al.
6969604 November 29, 2005 Yakovenko
D621060 August 3, 2010 Handique
D669191 October 16, 2012 Handique
D879999 March 31, 2020 Wronko
11046976 June 29, 2021 Wu
20040197883 October 7, 2004 Dzekunov et al.
20050118705 June 2, 2005 Rabbitt et al.
20060057245 March 16, 2006 Haupt
20090166201 July 2, 2009 Tian
20100216126 August 26, 2010 Balachandran
20130256132 October 3, 2013 Chen
20140332377 November 13, 2014 Su
20170010259 January 12, 2017 Amoabediny
20170037357 February 9, 2017 Cattaruzzi et al.
20170240945 August 24, 2017 Marquant
20170283761 October 5, 2017 Corso
20190136224 May 9, 2019 Garcia Dominguez et al.
20200017847 January 16, 2020 Chang
20200221987 July 16, 2020 Liu
20200238282 July 30, 2020 Burns
20200249232 August 6, 2020 Konstantopoulos
20200340014 October 29, 2020 Chang
20220025402 January 27, 2022 Chang et al.
20220088604 March 24, 2022 Yu
Foreign Patent Documents
101928666 April 2013 CN
103451097 December 2013 CN
106995783 August 2017 CN
208250332 December 2018 CN
D2019-7688 February 2020 JP
WO-2006112870 October 2006 WO
WO-2020014264 January 2020 WO
WO-2021007315 January 2021 WO
Other references
  • How microfluidics can automate drug discovery and development. Online, published day May 17, 2021. Retrieved on Sep. 11, 2022 from URL: https://www.drugtargetreview.com/article/91542/how-microfluidics-can-automate-drug-discovery-and-development/.
  • Book Chapter on Design and Fabrication of Microfluidic Devices Published. Online, published date Aug. 26, 2021. Retrieved on May 20, 2023 from URL: https://people.sutd.edu.sg/˜hashimoto/book-chapter-on-design-and-fabrication-of-microfluidic-devices-published/.
  • High flow rate microfluidic device for blood plasma separation using a range of temperatures. Online, published date 2010. Retrieved on May 20, 2023 from URL: https://pubs.rsc.org/en/content/articlelanding/2010/lc/b904531g.
  • Andresen et al., “Injection molded chips with integrated conducting polymer electrodes for electroporation of cells,” Journal of Micromechanics and Microengineering, 20: 1-9 (2010).
  • Boissel, L., et al., “Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells,” Leuk Res., 33(9): 1255-1259 (2009).
  • Choi et al., “A high throughput microeletroporatin device to introduce a chimeric antigen receptor to redirect the specificity of human T cells,” Biomed Microdevices, 12: 855-863 (2010).
  • Ding et al., “High-throught neclear delivery and repid expression of DNA via mechanical and electrical cell-membrane disruption,” Nature biomedical engineering, 1(39): 1-7 (2017).
  • Examination Report from corresponding Australian Application No. 2020311908 dated Feb. 10, 2022.
  • International Preliminary Report on Patentability from PCT Application No. PCT/US2019/041055 dated Sep. 15, 2020.
  • International Search Report from corresponding PCT Application No. PCT/US2020/041188 dated Oct. 21, 2020.
  • International Search Report from PCT Application No. PCT/US2019/041055 dated Sep. 23, 2019.
  • Jiang, W., et al., “Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL,” Cytotherapy, 10(3): 265-274 (2008).
  • Li, S., “Electroporation Protocols: Preclinical and clinical gene medicine,” Shulin Li (Ed.), Methods in Molecular Biology, 423: 1-511 (2008).
  • MaxCyte, “ExPERT GTx,” (2020).
  • MaxCyte, “EXPERT STx,” (2020).
  • MaxCyte, “MaxCyte VLX® Large-Scale Transfection System,” (2017).
  • Moffett, H.F., et al., “Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers,” Nature Communications, 8(389): 1-13 (2017).
  • Office Action from corresponding Japanese Application No. 2021-501021 dated Apr. 5, 2022.
  • Office Action from corresponding U.S. Appl. No. 16/506,190 dated Sep. 16, 2021.
  • Selmeczi et al., “Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip,” Biomed Microdevices, 13: 383-392 (2011).
  • Selmeczi et al., “Large scale mRNA Transfection of Dendritic Cells by Electroporation in Ccontinuous Flow Systems,” Methods in Molecular Biology, 1428 (Chapter 10) :151-161 (2016).
  • Wei, Z., et al., “A Laminar Flow Electroporation System for Efficient DNA and siRNA Delivery,” Analytical Chemistry, 83: 5881-5887 (2011).
  • Written Opinion from corresponding PCT Application No. PCT/US2020/041188 dated Oct. 21, 2020.
  • Written Opinion from PCT Application No. PCT/US2019/041055 dated Sep. 23, 2019.
  • Young, J.L. & Dean, D.A., “Electroporation-Mediated Gene Delivery,” Adv. Genet, 89: 49-88 (2015).
  • Zhao, D., et al., “A Flow-Through Cell Electroporation Device for Rapidly and Efficiently Transfecting Massive Amounts of Cells in vitro and ex vivo , ” Scientific Reports, 6: 1-9 (2016).
Patent History
Patent number: D1016324
Type: Grant
Filed: Oct 20, 2021
Date of Patent: Feb 27, 2024
Assignee: NanoCav, LLC (Culver City, CA)
Inventors: Chihwei Chang (Los Angeles, CA), Wade Richardson (Los Angeles, CA), Artin Mehrabi (Burbank, CA)
Primary Examiner: Omeed Agilee
Application Number: 29/812,292
Classifications